Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Shaji Kumar(Mayo Clinic), Rashmi Kumar(University of London), Leona Holmberg, Jason C. Chandler(West Cancer Center), James Omel(Island Institute), Kelly Godby(University of Alabama at Birmingham), Craig C. Hofmeister(The Ohio State University), George Somlo(City Of Hope National Medical Center), Djordje Atanackovic(University of Maryland, Baltimore), Cristina Gasparetto(Dana-Farber Cancer Institute), Seema Singhal(All India Institute of Medical Sciences), Natalie S. Callander(University of Wisconsin–Madison), Matthew Faiman, Adetola A. Kassim(Vanderbilt University), Noopur Raje(Massachusetts General Hospital), Frederic J. Reu(Deciphera Pharmaceuticals (United States)), Dorothy A. Shead(University of the Witwatersrand), Steven P. Treon(Dana-Farber Cancer Institute), Michaela Liedtke(Cancer Institute (WIA)), Melissa Alsina(Moffitt Cancer Center), Caitlin Costello(University of California San Diego), Carol Ann Huff(Sidney Kimmel Comprehensive Cancer Center), Keith Stockerl‐Goldstein(City Of Hope National Medical Center), Thomas Martin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), J. Sybil Biermann(American Society of Clinical Oncology), Henry C. Fung(Fox Chase Cancer Center), Sarah A. Holstein(University of Nebraska Medical Center), Donna Weber(The University of Texas MD Anderson Cancer Center), Joachim Yahalom(Unknown)
Cited by 282
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k